Skip to main content
SpringerLink
Log in

Health Economics for Neuropsychological Diseases in China

  • Living reference work entry
  • First Online:
NeuroPsychopharmacotherapy

  • 166 Accesses

Abstract

As an important economy branch dealing with the allocation of health-related resource, health economics mainly covers studies concentrating on issues related to multiple medical actions and disease researches concerning efficiency, effectiveness, value, and behavior in the production and consumption of both health and health care. The focus of this chapter is to give a brief introduction on the notions and definitions of the modern health economies, as well as the general containment of the works underlying this specific notion of study. Two commonly seen neuropsychological or neurodegenerative diseases (Parkinson’s disease and Alzheimer’s disease), both inconvertible and with relatively lengthy process, are specifically described in order to illustrate the work of health economies in a well-understood manner. The calculation of the economic burden and the process of financial evaluation of the two examples would help demonstrate the importance of economic planning of health problems.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  • Allegri RF, Butman J, Arizaga RL, Machnicki G, Serrano C, Taragano FE, Sarasola D, Lon L. Economic impact of dementia in developing countries: an evaluation of costs of Alzheimer-type dementia in Argentina. Int Psychogeriatr. 2007;19(4):705–18.

    Article  Google Scholar 

  • Anderson GF, Chalkidou K. Spending on medical care: more is better? JAMA. 2008;299(20): 2444–5.

    Article  CAS  Google Scholar 

  • Bragaglia P, O’Brien L. Chronic disease management: the primary care perspective. Healthc Pap. 2007;7(4):26–8; discussion 68–70.

    Article  Google Scholar 

  • Dodel RC, Haacke C, Zamzow K, Paweilik S, Spottke A, Rethfeldt M, Siebert U, Oertel WH, Schoffski O, Back T. Resource utilization and costs of stroke unit care in Germany. Value Health. 2004;7(2):144–52.

    Article  Google Scholar 

  • Durrani H. Healthcare and healthcare systems: inspiring progress and future prospects. mHealth. 2016;2:3.

    PubMed  PubMed Central  Google Scholar 

  • Fan VY, Savedoff WD. The health financing transition: a conceptual framework and empirical evidence. Soc Sci Med. 2014;105:112–21.

    Article  Google Scholar 

  • Fan J, Dawson TM, Dawson VL. Cell death mechanisms of neurodegeneration. Adv Neurobiol. 2017;15:403–25.

    Article  Google Scholar 

  • Garibaldi P, Martins JO, van Ours J. Ageing, health, and productivity: the economics of increased life expectancy. Oxford: Oxford University Press; 2010.

    Book  Google Scholar 

  • Gooch CL, Pracht E, Borenstein AR. The burden of neurological disease in the United States: a summary report and call to action. Ann Neurol. 2017;81(4):479–84.

    Article  Google Scholar 

  • Guerriere DN, Tranmer JE, Ungar WJ, Manoharan V, Coyte PC. Valuing care recipient and family caregiver time: A comparison of methods. International Journal of Technology Assessment in Health Care. 2008;24(01):52–9.

    Article  Google Scholar 

  • Hall RE, Jones CI. The value of life and the rise in health spending. Q J Econ. 2007;122(1):39–72.

    Article  Google Scholar 

  • Harrow BS, Mahoney DF, Mendelsohn AB, Ory MG, Coon DW, Belle SH, Nichols LO. Variation in cost of informal caregiving and formal-service use for people with Alzheimer’s desease. American Journal of Alzheimer’s Disease & Other Dementias. 2004;19(5):299–308.

    Google Scholar 

  • Jia J, Zhou A, Wei C, Jia X, Wang F, Li F, Wu X, Mok V, Gauthier S, Tang M, Chu L, Zhou Y, Zhou C, Cui Y, Wang Q, Wang W, Yin P, Hu N, Zuo X, Song H, Qin W, Wu L, Li D, Jia L, Song J, Han Y, Xing Y, Yang P, Li Y, Qiao Y, Tang Y, Lv J, Dong X. The prevalence of mild cognitive impairment and its etiological subtypes in elderly Chinese. Alzheimers Dement. 2014;10(4):439–47.

    Article  Google Scholar 

  • Jonsson L, Eriksdotter Jonhagen M, Kilander L, Soininen H, Hallikainen M, Waldemar G, Nygaard H, Andreasen N, Winblad B, Wimo A. Determinants of costs of care for patients with Alzheimer’s disease. Int J Geriatr Psychiatry. 2006;21(5):449–59.

    Article  Google Scholar 

  • Kowal SL, Dall TM, Chakrabarti R, Storm MV, Jain A. The current and projected economic burden of Parkinson’s disease in the United States. Mov Disord. 2013;28(3):311–8.

    Article  Google Scholar 

  • Langa KM, Larson EB, Crimmins EM, Faul JD, Levine DA, Kabeto MU, Weir DR. A comparison of the prevalence of dementia in the United States in 2000 and 2012. JAMA Intern Med. 2017;177(1):51–8.

    Article  Google Scholar 

  • Liu N, Zhang J, Guo L. Alzheimer’s disease epidemiological situation. J Liaoning Univ Tradit Chin Med. 2011;1:35–6.

    Google Scholar 

  • Manes F. The huge burden of dementia in Latin America. Lancet Neurol. 2016;15(1):29.

    Article  Google Scholar 

  • Morris S, Patel N, Baio G, Kelly L, Lewis-Holmes E, Omar RZ, Katona C, Cooper C, Livingston G. Monetary costs of agitation in older adults with Alzheimer’s disease in the UK: prospective cohort study. BMJ Open. 2015;5(3):e007382.

    Article  Google Scholar 

  • Muangpaisan W, Hori H, Brayne C. Systematic review of the prevalence and incidence of Parkinson’s disease in Asia. J Epidemiol. 2009;19(6):281–93.

    Article  Google Scholar 

  • Park M, Sung M, Kim SK, Kim S, Lee DY. Multidimensional determinants of family caregiver burden in Alzheimer’s disease. Int Psychogeriatr. 2015;27(8):1355–64.

    Article  Google Scholar 

  • Prince M. Care arrangements for people with dementia in developing countries. Int J Geriatr Psychiatry. 2004;19(2):170–7.

    Article  Google Scholar 

  • Rajput AH, Offord KP, Beard CM, Kurland LT. Epidemiology of parkinsonism: incidence, classification, and mortality. Ann Neurol. 1984;16(3):278–82.

    Article  CAS  Google Scholar 

  • Sorenson C, Drummond M, Bhuiyan Khan B. Medical technology as a key driver of rising health expenditure: disentangling the relationship. Clinicoecon Outcomes Res. 2013;5:223–34.

    Article  Google Scholar 

  • von Campenhausen S, Bornschein B, Wick R, Botzel K, Sampaio C, Poewe W, Oertel W, Siebert U, Berger K, Dodel R. Prevalence and incidence of Parkinson’s disease in Europe. Eur Neuropsychopharmacol. 2005;15(4):473–90.

    Article  Google Scholar 

  • Wang G, Cheng Q, Zheng R, Tan YY, Sun XK, Zhou HY, Ye XL, Wang Y, Wang Z, Sun BM, Chen SD. Economic burden of Parkinson’s disease in a developing country: a retrospective cost analysis in Shanghai, China. Mov Disord. 2006;21(9):1439–43.

    Article  Google Scholar 

  • Wang G, Cheng Q, Zhang S, Bai L, Zeng J, Cui PJ, Zhang T, Sun ZK, Ren RJ, Deng YL, Xu W, Wang Y, Chen SD. Economic Impact of Dementia in Developing Countries: An Evaluation of Alzheimer-Type Dementia in Shanghai, China. Journal of Alzheimer’s Disease. 2008;15(1):109–15.

    Article  Google Scholar 

  • Wang J, Xiao LD, He GP, De Bellis A. Family caregiver challenges in dementia care in a country with undeveloped dementia services. J Adv Nurs. 2014;70(6):1369–80.

    Article  Google Scholar 

  • Williams A. Health and Economics. Palgrave Macmillan, London. 1987.

    Google Scholar 

  • Wong YC, Leung J. Long-term care in China: issues and prospects. J Gerontol Soc Work. 2012; 55(7):570–86.

    Article  Google Scholar 

  • Wu C, Gao L, Chen S, Dong H. Care services for elderly people with dementia in rural China: a case study. Bull World Health Organ. 2016;94(3):167–73.

    Article  Google Scholar 

  • Yang Z, Lin PJ, Levey A. Monetary costs of dementia in the United States. N Engl J Med. 2013; 369(5):489.

    Article  CAS  Google Scholar 

  • Zencir M, Kuzu N, Beser NG, Ergin A, Catak B, Sahiner T. Cost of Alzheimer’s disease in a developing country setting. Int J Geriatr Psychiatry. 2005;20(7):616–22.

    Article  CAS  Google Scholar 

  • Zhang Y, Xu Y, Nie H, Lei T, Wu Y, Zhang L, Zhang M. Prevalence of dementia and major dementia subtypes in the Chinese populations: a meta-analysis of dementia prevalence surveys, 1980–2010. J Clin Neurosci. 2012;19(10):1333–7.

    Article  Google Scholar 

  • Zhang H, Loi SM, Zhou S, Zhao M, Lv X, Wang J, Wang X, Lautenschlager N, Yu X, Wang H. Dementia literacy among community-dwelling older adults in urban China: a cross-sectional study. Front Public Health. 2017;5:124.

    Article  Google Scholar 

  • Zhu CW, Scarmeas N, Torgan R, Albert M, Brandt J, Blacker D, Sano M, Stern Y. Clinical features associated with costs in early AD: baseline data from the Predictors Study. Neurology. 2006; 66(7):1021–8.

    Article  CAS  Google Scholar 

  • Zou YM, Liu J, Tian ZY, Lu D, Zhou YY. Systematic review of the prevalence and incidence of Parkinson’s disease in the People’s Republic of China. Neuropsychiatr Dis Treat. 2015;11:1467–72.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology and Neuroscience Institute, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, P.R. China

    Hai-lun Cui & Gang Wang

Authors
  1. Hai-lun Cui
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gang Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gang Wang .

Editor information

Editors and Affiliations

  1. Dept Psychiatry , Psychosomatics & Psychotherapy, University of Würzburg, Medical School Clinical Neurochemistry, Würzburg, Germany

    Peter Riederer

  2. Inst für Psychologische Medizin, Haag, Bayern, Germany

    Gerd Laux

  3. Department of Psychiatry, University of Toronto Department of Psychiatry, Toronto, ON, Canada

    Benoit Mulsant

  4. Center Translational Res Neurol Diseases, Dalian Med Uni Shanghai Inst Health Sc Center Translational Res Neurol Diseases, Dalian, China

    Weidong Le

  5. Fujita Health University School Medicine, Toyoake, Aichi, Japan

    Toshiharu Nagatsu

Section Editor information

  1. University Hospital, Center for Mental Health, Clinic and Policlinic for Psychiatry, Psychosomatics and Psychotherapy, University Wuerzburg, Wuerzburg, Germany

    Peter Riederer

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Cui, Hl., Wang, G. (2020). Health Economics for Neuropsychological Diseases in China. In: Riederer, P., Laux, G., Mulsant, B., Le, W., Nagatsu, T. (eds) NeuroPsychopharmacotherapy. Springer, Cham. https://doi.org/10.1007/978-3-319-56015-1_17-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-56015-1_17-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-56015-1

  • Online ISBN: 978-3-319-56015-1

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation